Results 21 to 30 of about 1,946 (125)
A glycoproteomic approach to the structural characterization of acidic glycoproteins
Glycoproteins, and their subset proteoglycans, are an important group of molecules in joint tissues, providing crucial functions such as cartilage structural integrity and lubrication at cartilage surfaces.
Estrella, Ruby Poblete
core +1 more source
Accès à l'information biomédicale : vers une approche d'indexation et de recherche d'information conceptuelle basée sur la fusion de ressources termino-ontologiques [PDF]
La recherche d'information (RI) est une discipline scientifique qui a pour objectif de produire des solutions permettant de sélectionner à partir de corpus d'information celle qui sont dites pertinentes pour un utilisateur ayant exprimé une requête. Dans
Dinh, Ba-Duy
core
Development of protein engineered enzymes for the study of galactosaminoglycan neuromedicine [PDF]
Thesis (Ph. D.)--Massachusetts Institute of Technology, Biological Engineering Division, 2006."June 2006."Includes bibliographical references.Glycans are chemically heterogeneous macromolecules that have profound importance in a variety of biological ...
Prabhakar, Vikas
core
Aggrecan-derived chondroitin sulfate (CS) chains, released by beta-elimination, were derivatized with p-aminobenzoic acid or p-aminophenol; radioiodinated; and subjected to graded or complete degradations by chondroitin ABC lyase to generate linkage ...
Anson +32 more
core +1 more source
Mucopolysaccharidosis (MPS) is a genetic disorder characterized by the accumulation of glycosaminoglycans in the body. Of the multiple MPS disease subtypes, several are caused by defects in sulfatases.
R. Mashima +3 more
semanticscholar +1 more source
BACKGROUND Mucopolysaccharidosis VI (MPS VI) is a lysosomal storage disease characterized by an absence or marked reduction of lysosomal N-acetylgalactosamine-4-sulfatase activity.
Therese Ruane +8 more
semanticscholar +1 more source
Mucopolysaccharidosis type VI (MPS VI) is a rare autosomal recessive disorder caused by a deficiency of N-acetylgalactosamine-4-sulfatase (ARSB), one of the enzymes required for the degradation of dermatan sulfate (DS).
Wei-De Lin +4 more
semanticscholar +1 more source
Background:The enzyme arylsulfatase B (ARSB; N-acetylgalactosamine-4-sulfatase) degrades chondroitin-4-sulfate (C4S) and is reduced in malignant colonic and mammary tissues but has not previously been evaluated in prostate cancer.Methods:ARSB ...
L. Feferman +6 more
semanticscholar +1 more source
Immunostaining in lungs of patients who died with COVID-19 infection showed increased intensity and distribution of chondroitin sulfate and decline in N-acetylgalactostamine-4-sulfatase (Arylsulfatase B; ARSB).
S. Bhattacharyya, J. Tobacman
semanticscholar +1 more source
The effects of the enzyme N-acetylgalactosamine-4-sulfatase (Arylsulfatase B, ARSB), which removes the 4-sulfate group at the non-reducing end of chondroitin 4-sulfate, on the expression of PD-L1 were determined, and the underlying mechanism of PD-L1 ...
S. Bhattacharyya +2 more
semanticscholar +1 more source

